Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-15 · accession 0001209191-21-070094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-16 | 2021-12-15 | ALXO | Randolph Sophia | Chief Medical Off, Dir | M - OptEx | $1.42 | +23.9K | 177.3K | +16% | +$33.8K |
| DM | 2021-12-16 | 2021-12-15 | ALXO | Randolph Sophia | Chief Medical Off, Dir | M - OptEx | $0.00 | -23.9K | 12.4K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-15 | M | A | 11,059 | $1.91 | 188,396 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-15 | M | A | 12,793 | $0.99 | 177,337 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2021-12-15 | M | D | 12,793 | $0.00 | 0 | D | $0.99 · — to 2027-03-30 | 12,793 Common Stock | (F1) Shares subject to the option are fully vested and immediately exercisable. |
| 4 | Derivative | Stock Option (right to buy) | 2021-12-15 | M | D | 11,059 | $0.00 | 12,431 | D | $1.91 · — to 2029-09-12 | 11,059 Common Stock | (F2) The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020. |